Key Highlights
• Bioreactors are containers as well as manufacturing instruments that are utilised for the biological responses that include different organisms, such as cultivating bacteria and yeast or even mammalian cells when they are given an ideal environment. The sustainable environment during the creation of a product maintains this cell's growth. Bioreactors are used by the pharmaceutical and biotechnology industries to create biological products, antibodies, and even vaccinations. Bioreactors, which are utilised for treating chronic diseases, are also employed in industrial operations to subject or develop various organisms. Bioreactors are widely used in medicinal products under strictly controlled circumstances.
• The global bioreactors market size was evaluated at USD 11.03 billion in 2022 and it is expected to hold around USD 32.48 billion by 2032, growing at a CAGR of 13.3% between 2023 and 2032.
• In June'22, ABEC confirmed that mAbxience would add a second 4,000L one-time-use custom single-run (CSR) bioreactor to their cutting-edge cGMP facility in León, Spain.
• The biotechnology and pharmaceutical industries both utilise bioreactors to the fullest extent. The market is anticipated to expand as these two industries expand and develop. The usage of sophisticated bioreactors and other modern equipment is anticipated to be greatly aided by technological advancement. Screens may be used to monitor cultivation factors, and the market will expand as a result of all these cutting-edge features. Such advancements allow for the collection of high-quality data while simultaneously reducing the need for human intervention.
Scope of the Industry Profile
Key Players
• GE Healthcare
• Merck KGaA
• Eppendorf AG
• Sartorius AG
• Thermo Fisher Scientific Inc.
• BBI-Biotech GmbH
• Bioengineering AG
• Danaher Corporation
• Getinge
• Infos HT
• Solaris Biotech Solutions
Segmentation
By Usage
• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production
By Scale (In Litres)
• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L
By Material
• Glass
• Stainless Steel
• Others
By Control Type
• Manual
• Automated (MFCs)
By Suppliers
• OEMs (Original Equipment Manufacturers)
• System Integrators
• EPCs (Engineering Procurement and Construction)
By End-Use
• Research and Development (R&D) Organizations
• Biopharmaceutical (biopharma) Manufacturers
• Contract Manufacturing Organizations (CMOS)
What To Expect from Industry Profile
1. Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Bioreactors market in the world.
2. Use the PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the Global Bioreactors market.
3. Leading company profiles reveal details of key Bioreactors market players’ global operations, strategies, financial performance & their recent developments.
4. Add weight to presentations and pitches by understanding the future growth prospects of the Global Bioreactors market with forecast for decade by both market share (%) & revenue (USD Million).
Recent Developments
• October’22: Getinge AB declared that its bioreactors will aid the Dutch government's effort to generate animal products like meat and milk proteins straight from animal & microbial cells.
• May’22: The IBIS (Institute of Biomedicine of Seville) employed the Pall Corporation's ICELL nano bioreactor to assist in the development of viral vectors for CAR-T treatment.
• March’21: Large-scale single-use systems are in high demand, which led Thermo Fisher Scientific to introduce the HyPerforma DynaDrive 3,000 L and HyPerforma DynaDrive 5,000 L single-use bioreactors.
• May’21: Beckman Coulter Life Sciences unveiled its newest Biolector XT Microbioreactor. Monitoring cultivation parameters, high-throughput strain screens, and feeding strategy optimisation are all made possible by the BioLector XT Microbioreactor.
• February’21: With the deployment of nine 4,000L single-use bioreactors, WuXi Biologics' MFG5 Drug Substance (DS) manufacturing facility in China effectively inaugurated a GMP operation with a capacity of 36,000L. With the GMP launch of MFG5, WuXi Biologics' current storage capacity has increased to 90,000L, marking a significant milestone in the company's worldwide capacity planning and significantly boosting its ability to enable international partners.
Segment Insights
• During the study's forecast period, single-use bioreactors (SUB), a material type segmentation, are anticipated to have rapid expansion. Single-use bioreactors have recently been used more frequently in contemporary biopharmaceutical operations. This is mainly because of their exceptional capacity to increase flexibility, lower investment, and minimise operational costs.
• Based on usage, the market was dominated by the pilot-scale production segment in 2020 and is predicted to do so again during the forecast period due to the rise in chronic disease prevalence, advancements in the pharmaceutical and biotechnology industries, and an increase in the number of clinical and pre-clinical trial studies. However, due to the expansion of scientific research for vaccine development and the spike in use of modern bioreactors, the full-scale production sector is anticipated to have significant growth over the forecast period.
• Based on control type, the automated category dominated the market in 2020 and is anticipated to maintain this trend over the course of the forecast period. This is due to the rise in chronic disease prevalence, the rapid uptake of cell culture technology, and improvements in R&D activities for the creation of personalised medicine.
Regional Insights
• The market is now dominated by North America, and this dominance is anticipated to last for a few more years. Due to increased industrial and academic institution collaboration, this area is anticipated to grow and dominate the market in the future. Due to multimillion dollar expenditures made by manufacturers of pharmaceuticals and high-tech products to increase their manufacturing capacity, the United States currently occupies a significant portion of the market across the North American region.
1 INTRODUCTION
1.1 Study Objectives
1.2 Market Definitions
1.2.1 Inclusions & Exclusions
1.2.2 Region: Inclusions & Exclusions
1.2.3 Study Scope
1.2.3.1 Markets Covered
1.2.3.2 Regional Scope
1.2.3.3 Years Considered
1.2.4 Currency Considered
1.2.5 Limitations
1.2.6 Summary Of Report (Chapter Wise Summary)
2 RESEARCH
METHODOLOGY
2.1 Research Data
2.1.1 Secondary & Primary Research
2.1.2 Secondary Data
2.1.2.1 Secondary Sources
2.1.3 Primary Data
2.1.3.1 Primary Sources
2.2 Market Breakdown & Data
Triangulation
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Research Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 EXECUTIVE
SUMMARY
4 ACROSS
THE GLOBE
4.1 Upcoming Attractive Market
Opportunities
4.2 Country Wise Market Growth
4.3 Segment Wise Market Growth
5 MARKET
OVERVIEW
5.1 Market Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
5.3 PORTOR’S Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Market Premium insights (Enterprise
license)
5.4.1 Case Study Analysis
5.4.2 Country Wise Import & Export Data (If
Applicable)
5.4.3 Regulatory Bodies & Authorization
Across the Globe
5.4.4 Key Conferences & Events: 2022 &
2023
5.4.5 Top Patents for The Market: 2022
6 BIOREACTORS
MARKET OVERVIEW, BY USAGE
6.1 Global Market Revenue & Share
Analysis, By Usage
6.1.1 Lab-Scale Production
6.1.2 Pilot-Scale Production
6.1.3 Full-Scale Production
6.2 Global Market Revenue & Share
Analysis, 2018 – 2022
6.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
6.4 Key Takeaways
7 BIOREACTORS
MARKET OVERVIEW, BY SCALE (IN LITRES)
7.1 Global Market Revenue & Share
Analysis, By Scale (In Litres)
7.1.1 5L-20L
7.1.2 20L-200L
7.1.3 200L-1500L
7.1.4 Above 1500L
7.2 Global Market Revenue & Share
Analysis, 2018 – 2022
7.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
7.4 Key Takeaways
8 BIOREACTORS
MARKET OVERVIEW, BY MATERIAL
8.1 Global Market Revenue & Share
Analysis, By Material
8.1.1 Glass
8.1.2 Stainless Steel
8.1.3 Others
8.2 Global Market Revenue & Share
Analysis, 2018 – 2022
8.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
8.4 Key Takeaways
9 BIOREACTORS
MARKET OVERVIEW, BY CONTROL TYPE
9.1 Global Market Revenue & Share
Analysis, By Control Type
9.1.1 Manual
9.1.2 Automated (MFCs)
9.2 Global Market Revenue & Share
Analysis, 2018 – 2022
9.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
9.4 Key Takeaways
10 BIOREACTORS
MARKET OVERVIEW, BY SUPPLIERS
10.1 Global Market Revenue & Share
Analysis, By Suppliers
10.1.1 OEMs (Original Equipment Manufacturers)
10.1.2 System Integrators
10.1.3 EPCs (Engineering Procurement and
Construction)
10.2 Global Market Revenue & Share
Analysis, 2018 – 2022
10.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
10.4 Key Takeaways
11 BIOREACTORS
MARKET OVERVIEW, BY END USE
11.1 Global Market Revenue & Share Analysis,
By End Use
11.1.1 Research and Development (R&D)
Organizations
11.1.2 Biopharmaceutical (biopharma) Manufacturers
11.1.3 Contract Manufacturing Organizations (CMOS)
11.2 Global Market Revenue & Share
Analysis, 2018 – 2022
11.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
11.4 Key Takeaways
12 BIOREACTORS
MARKET OVERVIEW, BY REGION
12.1 Global Market Revenue & Share
Analysis, By Region
12.1.1 North America
12.1.2 Europe
12.1.3 Asia Pacific
12.1.4 Middle East & Africa
12.1.5 South America
12.2 Global Market Revenue & Share
Analysis, 2018 – 2022
12.3 Global Market Revenue & Share
Forecast Analysis, 2023 – 2032
12.4 Key Takeaways
13 NORTH
AMERICA MARKET ANALYSIS
13.1 North America Market Revenue & Share
Analysis, By Usage
13.2 North America Market Revenue & Share
Analysis, By Scale (In Litres)
13.3 North America Market Revenue & Share
Analysis, By Material
13.4 North America Market Revenue & Share
Analysis, By Control Type
13.5 North America Market Revenue & Share
Analysis, By Suppliers
13.6 North America Market Revenue & Share
Analysis, By End Use
13.7 North America Market Revenue & Share
Analysis, By Country
13.7.1 US
13.7.2 Canada
13.7.3 Mexico
13.8 Key Takeaways
14 EUROPE
MARKET ANALYSIS
14.1 Europe Market Revenue & Share
Analysis, By Usage
14.2 Europe Market Revenue & Share
Analysis, By Scale (In Litres)
14.3 Europe Market Revenue & Share
Analysis, By Material
14.4 Europe Market Revenue & Share
Analysis, By Control Type
14.5 Europe Market Revenue & Share
Analysis, By Suppliers
14.6 Europe Market Revenue & Share
Analysis, By End Use
14.7 Europe Market Revenue & Share
Analysis, By Country
14.7.1 UK
14.7.2 Italy
14.7.3 Spain
14.7.4 Germany
14.7.5 France
14.7.6 Rest of Europe
14.8 Key Takeaways
15 ASIA
PACIFIC MARKET ANALYSIS
15.1 APAC Market Revenue & Share Analysis,
By Usage
15.2 APAC Market Revenue & Share Analysis,
By Scale (In Litres)
15.3 APAC Market Revenue & Share Analysis,
By Material
15.4 APAC Market Revenue & Share Analysis,
By Control Type
15.5 APAC Market Revenue & Share Analysis,
By Suppliers
15.6 APAC Market Revenue & Share Analysis,
By End Use
15.7 APAC Market Revenue & Share Analysis,
By Country
15.7.1 China
15.7.2 Japan
15.7.3 India
15.7.4 South Korea
15.7.5 Rest of APAC
15.8 Key Takeaways
16 MIDDLE
EAST & AFRICA MARKET ANALYSIS
16.1 MEA Market Revenue & Share Analysis,
By Usage
16.2 MEA Market Revenue & Share Analysis,
By Scale (In Litres)
16.3 MEA Market Revenue & Share Analysis,
By Material
16.4 MEA Market Revenue & Share Analysis,
By Control Type
16.5 MEA Market Revenue & Share Analysis,
By Suppliers
16.6 MEA Market Revenue & Share Analysis,
By End Use
16.7 MEA Market Revenue & Share Analysis,
By Country
16.7.1 GCC
16.7.2 South Africa
16.7.3 Rest of MEA
16.8 Key Takeaways
17 SOUTH
AMERICA MARKET ANALYSIS
17.1 SA Market Revenue & Share Analysis,
By Usage
17.2 SA Market Revenue & Share Analysis,
By Scale (In Litres)
17.3 SA Market Revenue & Share Analysis,
By Material
17.4 SA Market Revenue & Share Analysis,
By Control Type
17.5 SA Market Revenue & Share Analysis,
By Suppliers
17.6 SA Market Revenue & Share Analysis,
By End Use
17.7 SA Market Revenue & Share Analysis,
By Country
17.7.1 Brazil
17.7.2 Argentina
17.7.3 Rest of SA
17.8 Key Takeaways
18 COMPETITIVE
SCENARIO
18.1 Overview
18.2 Key Players Market Share Analysis
18.3 Recent Developments & Product
Launches
18.4 Mergers & Acquisitions
18.5 Partnerships, Agreements &
Collaborations
19 COMPANY
PROFILES
19.1 Overview
19.2 Key players
19.2.1 GE Healthcare
19.2.1.1 Business Overview
19.2.1.2 Products Offered
19.2.1.3 Financial Insights
19.2.1.4 Strategic Developments
19.2.1.4.1 New Product Launches
19.2.1.4.2 Agreements & Collaborations
19.2.1.5 Business Aspects (NOISE Analysis)
19.2.1.5.1 Key Strengths
19.2.1.5.2 Opportunities
19.2.1.5.3 Weaknesses & Competitive Threats
19.2.1.5.4 Needs & Improvements
19.2.2 Merck KGaA
19.2.3 Sartorius AG
19.2.4 Eppendorf AG
19.2.5 Thermo Fisher Scientific Inc.
19.2.6 BBI-Biotech GmbH
19.2.7 Bioengineering AG
19.2.8 Danaher Corporation
19.2.9 Getinge
19.2.10 Infos HT
20 DISCLAIMER
21 APPENDIX
